Filing Details

Accession Number:
0000905148-20-001292
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-18 18:43:27
Reporting Period:
2020-12-16
Accepted Time:
2020-12-18 18:43:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70318 Tenet Healthcare Corp THC Services-General Medical & Surgical Hospitals, Nec (8062) 952557091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1138995 Glenview Capital Management, Llc 767 Fifth Avenue
44Th Floor
New York NY 10153
No No No No
1228603 Larry Robbins 767 Fifth Avenue
44Th Floor
New York NY 10153
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.05 Par Value Disposition 2020-12-16 28,081 $40.75 18,480,878 No 4 S Indirect See footnotes
Common Stock, $0.05 Par Value Disposition 2020-12-16 12,363 $41.96 18,468,515 No 4 S Indirect See footnotes
Common Stock, $0.05 Par Value Disposition 2020-12-17 185,000 $41.19 18,283,515 No 4 S Indirect See footnotes
Common Stock, $0.05 Par Value Disposition 2020-12-18 77,099 $41.22 18,206,416 No 4 S Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
No 4 S Indirect See footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.05 Par Value 52,394 Direct
Footnotes
  1. These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC.
  2. These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.
  3. Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  4. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 16, 2020 within a $1.00 range. The actual prices for these transactions range from $40.59 to $41.32, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
  5. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 16, 2020 within a $1.00 range. The actual prices for these transactions range from $41.78 to $42.31, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
  6. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 17, 2020 within a $1.00 range. The actual prices for these transactions range from $41.00 to $41.71, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
  7. This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on December 18, 2020 within a $1.00 range. The actual prices for these transactions range from $40.88 to $41.43, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.